{"entity":{"type":"insider","cik":"0001676051","url":"/insider/0001676051","json_url":"/insider/0001676051.json","name":"Hertzberg Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":3,"first":"2016-06-14","last":"2016-11-01","span_basis":"filed_date"},"name_variants":[{"name":"Hertzberg Richard","source":"filing","n_filings":3,"first_seen":"2016-06-14","last_seen":"2016-11-01"}],"transactions":[{"id":3236634,"accession":"0001676051-16-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001676051-16-000006","line_url":"/filing/0001676051-16-000006#line-1","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Other","officer_title":null,"security_title":"Cellectar Biosciences, Inc. common stock (CLRB)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":2.029,"price_display":"2.03","price_state":"stated","total_value":42609.0,"total_display":"42,609.00","shares_owned_after":280000.0,"shares_owned_after_display":"280,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-11-01","scope":"insider"},{"id":2781842,"accession":"0001676051-16-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001676051-16-000004","line_url":"/filing/0001676051-16-000004#line-2","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Other","officer_title":null,"security_title":"Cellectar Biosciences, Inc.","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3758.0,"shares_display":"3,758","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":7140.2,"total_display":"7,140.20","shares_owned_after":301000.0,"shares_owned_after_display":"301,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-21","filed_date":"2016-06-14","scope":"insider"},{"id":2781835,"accession":"0001676051-16-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001676051-16-000004","line_url":"/filing/0001676051-16-000004#line-1","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Other","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":234742.0,"shares_display":"234,742","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":497653.04,"total_display":"497,653.04","shares_owned_after":297242.0,"shares_owned_after_display":"297,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-06-14","scope":"insider"},{"id":2345028,"accession":"0001676051-16-000003","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-10","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":54000.0,"total_display":"54,000.00","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-28","filed_date":"2016-06-14","scope":"insider"},{"id":2345024,"accession":"0001676051-16-000003","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-9","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.79,"price_display":"0.79","price_state":"stated","total_value":39500.0,"total_display":"39,500.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-24","filed_date":"2016-06-14","scope":"insider"},{"id":2345018,"accession":"0001676051-16-000003","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-8","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":4550.0,"total_display":"4,550.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-22","filed_date":"2016-06-14","scope":"insider"},{"id":2345009,"accession":"0001676051-16-000003","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-7","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19592.0,"shares_display":"19,592","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":17828.72,"total_display":"17,828.72","shares_owned_after":19592.0,"shares_owned_after_display":"19,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-16","filed_date":"2016-06-14","scope":"insider"},{"id":2344999,"accession":"0001676051-16-000003","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-6","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16250.0,"shares_display":"16,250","price_per_share":0.924,"price_display":"0.92","price_state":"stated","total_value":15015.0,"total_display":"15,015.00","shares_owned_after":16250.0,"shares_owned_after_display":"16,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2016-06-14","scope":"insider"},{"id":2344997,"accession":"0001676051-16-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-5","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.9225,"price_display":"0.92","price_state":"stated","total_value":9225.0,"total_display":"9,225.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-08","filed_date":"2016-06-14","scope":"insider"},{"id":2344993,"accession":"0001676051-16-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-4","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2016-06-14","scope":"insider"},{"id":2344989,"accession":"0001676051-16-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-3","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.67,"price_display":"2.67","price_state":"stated","total_value":53400.0,"total_display":"53,400.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2016-06-14","scope":"insider"},{"id":2344984,"accession":"0001676051-16-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-2","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Cellectar Biosciences, Inc. (CLRB) Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":409158.0,"shares_display":"409,158","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":1534342.5,"total_display":"1,534,342.50","shares_owned_after":409158.0,"shares_owned_after_display":"409,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2016-06-14","scope":"insider"},{"id":2344979,"accession":"0001676051-16-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001676051-16-000003","line_url":"/filing/0001676051-16-000003#line-1","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001676051","owner_name":"Hertzberg Richard","owner_url":"/insider/0001676051","role":"Ten percent owner","officer_title":null,"security_title":"Novelos Therapeutics, Inc. New (NVLT)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":120000.0,"total_display":"120,000.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-05","filed_date":"2016-06-14","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001279704","name":"Cellectar Biosciences, Inc.","url":"/issuer/0001279704","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2016-06-14","last_seen":"2016-11-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001676051","retrieved_at":"2026-08-21T11:04:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}